Looks similar to
To wait until relisting and buy then may not be that convenient, there were similar calls about paying a premium on the post consolidation CR for MTM earlier this year: I too couldn't work out why anyone was paying .007 for the pre-consolidation shares given that on a 40:1 consolidation -and 20c raising price - a fair price should have been .005 (instead buyers were paying about 40% premium).
Well the lowest it got since relisting was 26.5c on the opening day before hitting a high of 35c last month.
I think it's reasonable to expect that BOTANIX will trade in the low 30s once it relists.
Ann: Prospectus - Botanix Pharmaceuticals-BNE.AX, page-20
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.5¢ |
Change
-0.010(2.99%) |
Mkt cap ! $590.6M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 33.8¢ | 31.5¢ | $1.933M | 5.941M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 261016 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 125980 | 2 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |